These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32601164)

  • 1. Pharmacist-Driven Implementation of Fast Identification and Antimicrobial Susceptibility Testing Improves Outcomes for Patients with Gram-Negative Bacteremia and Candidemia.
    Sheth S; Miller M; Prouse AB; Baker S
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate Pheno
    Burnham JP; Wallace MA; Fuller BM; Shupe A; Burnham CD; Kollef MH
    J Appl Lab Med; 2019 Jan; 3(4):569-579. PubMed ID: 31639726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit.
    MacVane SH; Bhalodi AA; Dare RK; Rosenbaum ER; Wolfe K; Ford B; Ince D; Kinn P; Percival KM; Humphries RM
    J Antimicrob Chemother; 2021 Aug; 76(9):2453-2463. PubMed ID: 34021752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study.
    Bhalodi AA; MacVane SH; Ford B; Ince D; Kinn PM; Percival KM; Bremmer DN; Carr DR; Walsh TL; Bhatti MM; Shelburne SA; Humphries RM; Wolfe K; Rosenbaum ER; Dare RK; Kolev J; Madhusudhan M; Ben-Aderet MA; Morgan MA
    Clin Infect Dis; 2022 Aug; 75(2):269-277. PubMed ID: 34718456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.
    Schneider JG; Wood JB; Schmitt BH; Emery CL; Davis TE; Smith NW; Blevins S; Hiles J; Desai A; Wrin J; Bocian B; Manaloor JJ
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i16-i23. PubMed ID: 30690542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia.
    Huang AM; Newton D; Kunapuli A; Gandhi TN; Washer LL; Isip J; Collins CD; Nagel JL
    Clin Infect Dis; 2013 Nov; 57(9):1237-45. PubMed ID: 23899684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study.
    Brosh-Nissimov T; Tzur A; Grupel D; Cahan A; Ma'aravi N; Heled-Akiva M; Jawamis H; Leskes H; Barenboim E; Sorek N
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):62. PubMed ID: 37516885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections.
    Elliott G; Malczynski M; Barr VO; Aljefri D; Martin D; Sutton S; Zembower TR; Postelnick M; Qi C
    BMC Infect Dis; 2019 Nov; 19(1):942. PubMed ID: 31699044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia.
    Walsh TL; Bremmer DN; Moffa MA; Trienski TL; Buchanan C; Stefano K; Hand C; Taylor T; Kasarda K; Shively NR; Bhanot N; Cheronis N; DiSilvio BE; Cho CY; Carr DR
    Infection; 2021 Jun; 49(3):511-519. PubMed ID: 33528813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Performance and Impact of Accelerate Pheno for Gram-negative Bacteremia in Hospitalized Children.
    Lee M; Scardina T; Zheng X; Patel SJ
    Clin Ther; 2020 Sep; 42(9):1630-1636. PubMed ID: 32826063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study.
    Hogan CA; Ebunji B; Watz N; Kapphahn K; Rigdon J; Mui E; Meng L; Alegria W; Holubar M; Deresinski S; Banaei N
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32434782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients.
    Dare RK; Lusardi K; Pearson C; McCain KD; Daniels KB; Van S; Rico JC; Painter J; Lakkad M; Rosenbaum ER; Bariola JR
    Clin Infect Dis; 2021 Dec; 73(11):e4616-e4626. PubMed ID: 32463864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
    Babowicz F; LaPlante R; Mitchell C; O'Donnell JN; Tobin E; George M; Carreno JJ
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Rapid Susceptibility Testing System on the Management of Gram-Negative Bacteremia in a Network of Community Hospitals.
    Ganapathiraju I; Weichman B; Rogers KL; Bushman AM; Rosa R
    J Appl Lab Med; 2022 May; 7(3):776-781. PubMed ID: 35021189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system.
    Box MJ; Sullivan EL; Ortwine KN; Parmenter MA; Quigley MM; Aguilar-Higgins LM; MacIntosh CL; Goerke KF; Lim RA
    Pharmacotherapy; 2015 Mar; 35(3):269-76. PubMed ID: 25809178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with Positive Blood Cultures.
    Beganovic M; Costello M; Wieczorkiewicz SM
    J Clin Microbiol; 2017 May; 55(5):1437-1445. PubMed ID: 28228491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial Evaluating Clinical Impact of RAPid IDentification and Susceptibility Testing for Gram-negative Bacteremia: RAPIDS-GN.
    Banerjee R; Komarow L; Virk A; Rajapakse N; Schuetz AN; Dylla B; Earley M; Lok J; Kohner P; Ihde S; Cole N; Hines L; Reed K; Garner OB; Chandrasekaran S; de St Maurice A; Kanatani M; Curello J; Arias R; Swearingen W; Doernberg SB; Patel R
    Clin Infect Dis; 2021 Jul; 73(1):e39-e46. PubMed ID: 32374822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria.
    Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Fujimoto H; Nakaie K; Okada Y; Fujita A; Kawaguchi H; Shinoda Y; Nakamura Y; Kaneko Y; Yoshida H; Kakeya H
    J Infect Chemother; 2019 Dec; 25(12):1001-1006. PubMed ID: 31255524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerate PhenoTest
    Sofjan AK; Casey BO; Xu BA; Amadio J; Restrepo A; Alam MJ; Garey KW
    Ann Pharmacother; 2018 Aug; 52(8):754-762. PubMed ID: 29557208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.